Research Group
Chemopreventive Agent Development
Sponsor
UCSF Benioff Children's Hospital Oakland
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00489086
RATIONALE: Drugs used in chemotherapy, such as tazarotene, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying topical tazarotene to see how well it works in treating patients with basal cell skin cancer and basal cell nevus syndrome on the face.
PURPOSE: This phase II trial is studying topical tazarotene to see how well it works in treating patients with basal cell skin cancer and basal cell nevus syndrome on the face.
Intervention
tazarotene
Condition
Neoplastic Syndrome
Investigators
David R. Bickers, MD, Ervin Epstein, MD